LONDON--(BUSINESS WIRE)--The global 3D cardiac mapping systems market is poised to grow by USD 412.6 million during 2019-2023, progressing at a CAGR of around 10% during the forecast period. Request free sample pages

Read the 120-page report with TOC on 3D Cardiac Mapping Systems Market Analysis Report by Product (Contact 3D cardiac mapping systems and Non-contact 3D cardiac mapping systems), Geography (Asia, Europe, North America, and ROW), and the Segment Forecasts, 2019-2023.

https://www.technavio.com/report/global-3d-cardiac-mapping-systems-market-industry-analysis

The market is driven by the increasing prevalence of cardiac arrhythmias and related risk factors. In addition, the emergence of non-invasive 3D cardiac mapping systems is anticipated to boost the growth of the 3D cardiac mapping systems market.

The prevalence of cardiac arrhythmias is growing across the world. This has increased the occurrence of other risk factors such as high blood pressure, obesity, CVDs, and diabetes. The chances of developing cardiac arrhythmias increases with age. Improving life expectancies of people has significantly increased the geriatric population across the globe. These factors have increased the demand for early detection and treatment of cardiac arrhythmias, thereby driving the demand for 3D cardiac mapping systems.

Buy 1 Technavio report and get the second for 50% off. Buy 2 Technavio reports and get the third for free.

View market snapshot before purchasing

Major Five 3D Cardiac Mapping Systems Market Companies:

Abbott

Abbott operates the business through various segments such as cardiovascular and neuromodulation, diagnostics, nutritionals, established pharmaceuticals, and other. EnSite Precision cardiac mapping system is the key offering of the company. It helps in the mapping of most complex arrhythmia cases through a high level of automation, flexibility, and precision.

Boston Scientific Corporation

Boston Scientific Corporation operates the business across various segments such as MedSurg, Rhythm management, and Cardiovascular. RHYTHMIA HDx Mapping System is the key offering of the company. It offers density, resolution, and automation required for true HD mapping with the combination of a high-resolution mapping catheter, advanced noise-filtering hardware, and intelligent software.

Johnson & Johnson Services, Inc.

Johnson & Johnson Services, Inc. operates the business through various segments such as pharmaceutical, medical devices, and consumer. CARTO 3 System is the key offering of the company. It offers high-quality data points and integrates multiple data sets and images into one resource for highly detailed, real-time information.

Medtronic

Medtronic operates the business through various segments such as cardiac and vascular group, minimally invasive therapies group, restorative therapies group, and diabetes group. CardioInsight Noninvasive 3D Mapping System is the key offering of the company. It is a non-invasive mapping system that collects chest ECG signals and combines them with CT scan data to produce and display simultaneous, bi-atrial and biventricular, 3D cardiac maps.

MicroPort Scientific Corporation

MicroPort Scientific Corporation operates the business through various segments such as orthopedics devices business, cardiovascular devices business, endovascular devices business, electrophysiology devices business, neurovascular devices business, surgical devices business, and diabetes and endocrinal devices. Columbus 3D EP Navigation System is the key offering of the company. It features real-time electromagnetic device tracking with cardiac motion compensation, accurate geometric reconstruction of intracardiac chambers, automatic 3D image segmentation of cardiac chambers with a single click, and accurate preoperative CT image registration and integration.

Register for a free trial today and gain instant access to 17,000+ market research reports.

Technavio's SUBSCRIPTION platform

3D Cardiac Mapping Systems Product Outlook (Revenue, USD Million, 2019 - 2023)

3D Cardiac Mapping Systems Regional Outlook (Revenue, USD Million, 2019 - 2023)

Technavios sample reports are free of charge and contain multiple sections of the report, such as the market size and forecast, drivers, challenges, trends, and more. Request a free sample report

Related Reports on Healthcare include:

Global Cardiac Restoration Systems Market Global cardiac restoration systems market by product (mitral valve restoration systems and left ventricular restoration systems), end-users (hospitals, ASCs, and others), and geography (Asia, Europe, North America, and ROW).

Global Cardiac POC Testing Devices Market Global cardiac POC testing devices market by end-users (hospitals and laboratories, diagnostic centers, and ambulatory centers and physicians' clinics) and geography (Asia, Europe, North America, and ROW).

About Technavio

Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.

With over 500 specialized analysts, Technavios report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavios comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

If you are interested in more information, please contact our media team at media@technavio.com

Go here to see the original:
Global 3D Cardiac Mapping Systems Market 2019-2023 | Evolving Opportunities with Abbott and Boston Scientific Corporation | Technavio - Business Wire

Related Posts
January 9, 2020 at 8:45 am by Mr HomeBuilder
Category: Home Restoration